Zyban: A new aid to smoking cessation treatment - Will it work for psychiatric patients?

Journal of Psychosocial Nursing and Mental Health Services

Volumn 37, Issue 2, 1999, Pages 36-42

  Farnam, Catherine R ^a  

^a Vinfen Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; NICOTINE; PSYCHOTROPIC AGENT;

ARTICLE; DRUG COMBINATION; DRUG INTERACTION; HUMAN; MENTAL DISEASE; METHODOLOGY; PATHOPHYSIOLOGY; SMOKING CESSATION; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HUMANS; MENTAL DISORDERS; NICOTINE; PSYCHOTROPIC DRUGS; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER;

EID: 0033070262     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. American Psychiatric Association. (1996). Practice guideline for the treatment of patients with nicotine dependence. American Journal of Psychiatry, 153(Suppl. 10), 1-29.
2. Bezchlibynk-Butler, K.Z., Jeffries, J.J., & Martin, B.A. (1997). Clinical handbook of psychotropic drugs (7th ed.) Seattle, WA: Hogrefe & Huber Publishers.
3. Davidson, J. (1989). Seizures and bupropion: A review. Journal of Clinical Psychiatry, 50, 256-261.
4. Glaxo Wellcome product monograph. (1996 & 1997). Research Triangle Park, NC: Glaxo Wellcome, Inc.
5. Goff, D.C., Henderson, D.C., & Amico, E. (1992). Cigarette smoking in schizophrenia: Relationship to psychopathology and medication side effects. American Journal of Psychiatry, 149, 1189-1193.
6. Hughes J.R., & Francis, R.J. (1995). How to help psychiatric patients stop smoking. Psychiatric Services, 46, 435-436.
7. Hurt, R.D., Sachs, D.P.L., Glover, E.D., Offord, K.P., Johnston, A.A., & Dale, L.C. (1997). A comparison of sustained-release bupropion and placebo for smoking cessation. New England Journal of Medicine, 337, 1195-1202.
8. Hyde, T.M., & Weinberger, D.R. (1997). Seizures and schizophrenia. Schizophrenia Bulletin, 23, 611-622.
9. Johnston, A.A., Lineberry, C.G., Ascher, J.A., Davidson, J., Khayrallah, M.A., & Feighner, J.P. (1991). A 102-center prospective study of seizure in association with bupropion. Journal of Clinical Psychiatry, 52, 450-456.
10. Ketter, T.A., Jenkins, J.B., Schroeder, D.H., Pazzaglia, R.J., Marangell, L.B., & George, M.S. (1995). Carbamazepine but not valproate induces bupropion metabolism. Journal of Clinical Psychopharmacology, 15, 327-333.
11. Nemeroff, C.B., DeVane, S.L., & Pollock, B.G. (1996). Newer antidepressants and the cytochrome P450 system. American Journal of Psychiatry, 153, 311-320.
12. Schatzberg, A.F., Cole, J.O., & DeBattista, C. (1997). Manual of clinical psychopharmacology. Washington, DC: American Psychiatric Press.
13. Smrek, J.J., & Tornatore, F.L. (1996). Psychotropic medications: A desktop reference for mental health providers. Providence, RI: Manissess Communications Group, Inc.
14. Spiller, H.A., Ramoska, E.A., Krenzelok, E.P., Sheen, S.R., Borys, D.J., & Villalobos, D. (1994). Bupropion overdose: A 3-year multicenter retrospective analysis. American Journal of Emergency Medicine, 12, 43-45.
15. Storrow, A.B. (1994). Bupropion overdose and seizure. American Journal of Emergency Medicine, 12, 183-184.
16. Terry, P., & Katz, J.L. (1997). Dopaminergic mediation of the discriminative stimulus effects of bupropion in rats. Psychopharmacology, 134, 201-212.
17. The Medical Letter on Drugs and Therapeutics (1997). Bupropion (Zyban) for smoking cessation. The Medical Letter, Inc., 1007, 77-78.
18. Zeidonis, D., & George, T.P. (1997). Schizophrenia and nicotine use: Report of a pilot smoking cessation program and review of neurobiological and clinical issues. Schizophrenia Bulletin, 23, 247-254.